封面
市場調查報告書
商品編碼
1405856

獸醫整形外科市場規模、佔有率、趨勢分析報告:按產品類型、按動物類型、按應用、按給藥途徑、按最終用途、細分市場預測,2024-2030年

Veterinary Orthopedic Medicine Market Size, Share & Trends Analysis Report By Product Type, By Animal Type, By Application, By Route of Administration, By End-use, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

獸醫整形外科市場的成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計到2030年,全球獸用整形外科藥物市場規模將達到63.7億美元,2024年至2030年複合年成長率為8.4%。

再生醫學的興起和獸醫學中關節內粘稠補充療法產品的日益採用是市場成長的主要驅動力。根據勃林格殷格翰和美國動物醫院協會 (AAHA) 進行的一項研究,到 2022 年,五分之一的狗(即所有狗的 20%)將在其一生中經歷某種類型的關節問題。大多數動物的骨關節炎 (OA) 是由發育性整形外科疾病 (DOD) 引起的,某些犬種比其他犬種更容易出現關節畸形。

獸醫再生醫學的目的是恢復生病或受損細胞和組織的正常功能,包括基於細胞的治療等各種方法。間質基質細胞(MSC)、富血小板血漿(PRP)和自體血清製劑的使用在這個領域中很突出。這些治療方法目前用於治療狗、馬和貓等動物的肌腱、韌帶和關節/軟骨。這些治療主要以研究為基礎,更具體的臨床報告正在進行中。無論目前的用途如何,這一獸醫學分支都有望有效治療和管理獸醫疾病。

目前的再生療法如MSC、PRP等都屬於藥物範疇。因此,FDS 將這些產品歸入「細胞產品」類別進行監管。然而,迄今為止,這些治療方法均未獲得 FDA核准,且它們目前的使用屬於 FDA 的臨床實驗豁免範圍。在退化性關節病變 (DJD) 和 OA 中,關節摩擦會增加。將透明質酸等黏性補充品透過關節內注射到動物的滑膜關節中,以進一步潤滑關節,減少摩擦並幫助平滑運動。這些努力預計將有助於獸醫整形外科藥物疾病的有效管理,並推動市場成長。

獸醫整形外科市場報告亮點

  • 由於非類固醇抗發炎藥、類固醇等產品在治療獸醫整形外科藥物併發症的廣泛採用,2023年製藥部門的收益佔有率最高,超過51.8%。
  • 預計 2024 年至 2030 年,狗類市場將以最快的複合年成長率成長。
  • 2023 年,OA 細分市場佔據最大市場佔有率,達到 42.0%。預計 2024 年至 2030 年,關節發炎/疼痛領域的複合年成長率最快。
  • 透明質酸等補充品的使用增加以及在獸醫併發症中採用幹細胞治療正在促進市場成長。
  • 由於骨關節炎盛行率不斷上升、獸醫醫療保健基礎設施完善、政府對優質動物護理的支持以及美國寵物擁有率較高等因素,北美在市場上處於領先地位。
  • 2022 年 8 月,美國收購了 Afrivet Southern Africa Proprietary Limited,這是 Bimeda 持續擴張計畫的一部分,以擴大其地理足跡。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章獸醫整形外科市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 整形外科市場分析工具
    • 波特的分析
    • PESTEL分析

第4章獸用整形外科藥品市場:產品類型估算及趨勢分析

  • 細分儀表板
  • 獸用整形外科藥品市場:2023年及2030年解決方案波動分析
  • 生技藥品
    • 2018-2030 年生技藥品市場收益估計與預測
  • 黏性補充品
    • 2018-2030 年黏稠補充品市場收益估算與預測
  • 藥品
    • 2018-2030年醫藥市場收益估算與預測

第5章動物整形外科藥物市場:動物類型估計及趨勢分析

  • 細分儀表板
  • 獸用整形外科藥品市場:2023年及2030年技術變遷分析
  • 犬科動物
    • 2018-2030年犬類市場收益估計與預測
  • 貓科動物
    • 2018-2030 年貓科動物市場收益估算與預測
    • 2018-2030年馬匹市場收益估計與預測
    • 2018-2030年生牛市場收益估計與預測
    • 2018-2030年生豬市場收益估算與預測
  • 其他
    • 2018-2030 年其他市場收益估計與預測

第6章獸用整形外科藥品市場:應用預估及趨勢分析

  • 細分儀表板
  • 獸用整形外科藥品市場:2023年及2030年技術變遷分析
  • 骨關節炎
    • 2018-2030年骨關節炎市場收益估計與預測
  • 退化性關節病變 (DJD)
    • 退化性關節疾病
  • 關節發炎/疼痛
    • 2018-2030 年聯合發炎/疼痛市場收益估計與預測
  • 其他用途
    • 2018-2030 年其他應用市場收益估計與預測

第7章獸用整形外科藥品市場:給藥途徑估算及趨勢分析

  • 細分儀表板
  • 獸用整形外科藥品市場:2023年及2030年技術變遷分析
  • 口服
    • 2018-2030年口腔市場收益估計與預測
  • 胃腸外的
    • 2018-2030 年注射藥物市場收益估計與預測
  • 局部的
    • 2018-2030 年局部市場收益估計與預測

第8章獸用整形外科藥品市場:最終用途估計與趨勢分析

  • 細分儀表板
  • 獸醫整形外科市場:2023 年和 2030 年最終用途變化分析
  • 動物醫院
    • 2018-2030年獸醫院市場收益估算與預測
  • 動物診所
    • 2018-2030年動物診所市場收益估計與預測
  • 其他
    • 2018-2030 年其他市場收益估計與預測

第9章獸用整形外科藥物市場:區域估計及趨勢分析

  • 2023年及2030年按地區分類的獸用整形外科藥物市場佔有率
  • 北美洲
    • 2018-2030年北美獸用整形外科藥物市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲獸用整形外科藥品市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區獸醫整形外科市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲獸用整形外科藥品市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲獸用整形外科藥品市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司市場佔有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • Zoetis, Inc.
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health(Merck &Co. Inc.)
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Biogenesis Bago
    • Ardent Animal Health Llc.
    • Bioiberica SAU
    • PetVivo Holdings, Inc.(Spryng)
    • Contipro AS
    • VetStem, Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therepeutics
    • MEDREGO LLC
    • Bimeda US
    • Hyalogic
    • Hester Biosciences
Product Code: GVR-4-68040-167-6

Veterinary Orthopedic Medicine Market Growth & Trends:

The global veterinary orthopedic medicines market size is anticipated to reach USD 6.37 billion by 2030, registering a CAGR of 8.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing emergence of regenerative medicine and rise in the adoption of viscosupplementation products in veterinary medicine are the major factors contributing to market growth. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), in 2022, 1 in 5 dogs i.e., 20% of all dogs experience some joint issue in their lifetime. The majority of animals suffer from Osteoarthritis (OA) because of Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others.

The aim of regenerative medicine in veterinary medicine is to restore normal function to diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of mesenchymal stromal cells (MSCs), platelet-rich plasma (PRP) & autologous serum products is prominent in this field. Currently, these therapies are used in tendon, ligament, and joint/cartilage treatment in animals like dogs, horses & cats. These treatments are primarily research-based and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine promises effective treatment & management of veterinary diseases.

Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Therefore, FDS regulates them under the category "Cell-based Products"; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. Degenerative Joint Diseases (DJD) and OA cause a rise in friction in the joints. Viscosupplements, such as hyaluronic acid, are intra-articularly injected into the synovial joint of the animal, which further lubricates the joint to reduce friction and assist in smooth movement. Such initiatives are expected to help in the effective management of veterinary orthopedic conditions, thus driving market growth.

Veterinary Orthopedic Medicine Market Report Highlights:

  • The pharmaceuticals segment accounted for the highest revenue share of more than 51.8% in 2023 owing to the high adoption of products like NSAIDS, steroids, etc. in the treatment of veterinary orthopedic complications
  • The canine segment is expected to grow at the fastest CAGR from 2024 to 2030
  • The OA segment held the largest market share of 42.0% in 2023. The joint inflammation/pain segment is anticipated to witness the fastest CAGR from 2024 to 2030
  • Use of viscosupplements like hyaluronic acid and rising adoption of stem-cell therapy in veterinary complications contributed to market growth
  • North America led the market owing to factors, such as increasing prevalence of osteoarthritis, well-equipped veterinary care infrastructure, government support for quality animal care, and high pet adoption in the U.S.
  • In August 2022, Bimeda U.S. acquired Afrivet Southern Africa Proprietary Limited, a part of Bimeda's ongoing expansion program to increase its geographic footprint

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of Primary Research
    • 1.5.1. Data for Primary Interviews in North America
    • 1.5.2. Data for Primary Interviews in Europe
    • 1.5.3. Data for Primary Interviews in Asia Pacific
    • 1.5.4. Data for Primary Interviews in Latin America
    • 1.5.5. Data for Primary Interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Parent Market Analysis (Model 1)
      • 1.7.1.1. Approach 1: Parent Market approach
    • 1.7.2. Company Share Analysis (Model 2)
      • 1.7.2.1. Approach 2: Company Share approach
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Orthopedic Medicine Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Emergence of Regenerative Medicine
      • 3.2.1.2. Increasing Adoption of Viscosupplementation Products in Treatment of Musculoskeletal Disorders
      • 3.2.1.3. Rise in Prevalence of Osteoarthritis and other Degenerative Joint Diseases
      • 3.2.1.4. Rising Adoption of Stem Cell Therapy and Other Biologics in Veterinary Medicine
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Low Penetration of Importance of Veterinary Care in Under-developed Countries
      • 3.2.2.2. Thorough Regulatory Scrutiny
  • 3.3. Veterinary Orthopedic Medicine Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining Power of The Suppliers
      • 3.3.1.2. Bargaining Power of the Buyers
      • 3.3.1.3. Threats of Substitution
      • 3.3.1.4. Threats from New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Veterinary Orthopedic Medicine Market: Product type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Orthopedic Medicine Market: Solution Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Biologics
    • 4.3.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Viscosupplements
    • 4.4.1. Viscosupplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pharmaceuticals
    • 4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Orthopedic Medicine Market: Animal type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Canine
    • 5.3.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Feline
    • 5.4.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Equine
    • 5.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cattle
    • 5.6.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Swine
    • 5.7.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Orthopedic Medicine Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Osteoarthritis
    • 6.3.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Degenerative Joint Disease (DJD)
    • 6.4.1. Degenerative Joint Disease (DJD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Joint Inflammation/Pain
    • 6.5.1. Joint Inflammation/Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Orthopedic Medicine Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Orthopedic Medicine Market: Technology Movement Analysis, USD Million, 2023 & 2030
  • 7.3. Oral
    • 7.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Parenteral
    • 7.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Topical
    • 7.5.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Orthopedic Medicine Market: End-use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Veterinary Orthopedic Medicine Market: End-user Movement Analysis, USD Million, 2023 & 2030
  • 8.3. Veterinary Hospitals
    • 8.3.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Veterinary Clinics
    • 8.4.1. Veterinary Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Orthopedic Medicine Market: Regional Estimates & Trend Analysis

  • 9.1. Veterinary Orthopedic Medicine Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. Saudi Arabia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Market Share Analysis
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Zoetis, Inc.
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Boehringer Ingelheim
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Elanco Animal Health
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. American Regent, Inc.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. Merck Animal Health (Merck & Co. Inc.)
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Vetoquinol S.A.
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Ceva Sante Animale
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Virbac
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Biogenesis Bago
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Ardent Animal Health Llc.
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Bioiberica S.A.U
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. PetVivo Holdings, Inc. (Spryng)
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Contipro A.S.
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments
    • 10.6.14. VetStem, Inc.
      • 10.6.14.1. Participant's Overview
      • 10.6.14.2. Financial Performance
      • 10.6.14.3. Product Benchmarking
      • 10.6.14.4. Recent Developments
    • 10.6.15. Enso Discoveries
      • 10.6.15.1. Participant's Overview
      • 10.6.15.2. Financial Performance
      • 10.6.15.3. Product Benchmarking
      • 10.6.15.4. Recent Developments
    • 10.6.16. Contura Vet US
      • 10.6.16.1. Participant's Overview
      • 10.6.16.2. Financial Performance
      • 10.6.16.3. Product Benchmarking
      • 10.6.16.4. Recent Developments
    • 10.6.17. T-Cyte Therepeutics
      • 10.6.17.1. Participant's Overview
      • 10.6.17.2. Financial Performance
      • 10.6.17.3. Product Benchmarking
      • 10.6.17.4. Recent Developments
    • 10.6.18. MEDREGO LLC
      • 10.6.18.1. Participant's Overview
      • 10.6.18.2. Financial Performance
      • 10.6.18.3. Product Benchmarking
      • 10.6.18.4. Recent Developments
    • 10.6.19. Bimeda U.S.
      • 10.6.19.1. Participant's Overview
      • 10.6.19.2. Financial Performance
      • 10.6.19.3. Product Benchmarking
      • 10.6.19.4. Recent Developments
    • 10.6.20. Hyalogic
      • 10.6.20.1. Participant's Overview
      • 10.6.20.2. Financial Performance
      • 10.6.20.3. Product Benchmarking
      • 10.6.20.4. Recent Developments
    • 10.6.21. Hester Biosciences
      • 10.6.21.1. Participant's Overview
      • 10.6.21.2. Financial Performance
      • 10.6.21.3. Product Benchmarking
      • 10.6.21.4. Recent Developments

List of Tables

  • Table 1 Veterinary Orthopedic Medicine(Veterinary Orthopedic Medicine) market 2018 - 2030 (USD Million)
  • Table 2 Global market estimates and forecasts by region, 2018 - 2030 (USD Million)
  • Table 3 Global market estimates and forecasts By Product type, 2018 - 2030 (USD Million)
  • Table 4 Global market estimates and forecasts By Animal type, 2018 - 2030 (USD Million)
  • Table 5 Global market estimates and forecasts By Application, 2018 - 2030 (USD Million)
  • Table 6 Global market estimates and forecasts By Route of Administration, 2018 - 2030 (USD Million)
  • Table 7 Global market estimates and forecasts by End-use, 2018 - 2030 (USD Million)
  • Table 8 Veterinary Orthopedic Medicine- M&A, collaborations & partnership scenario
  • Table 9 Biologics Veterinary Orthopedic Medicine market by region, 2018 - 2030 (USD Million)
  • Table 10 Viscosupplements Veterinary Orthopedic Medicine market by region, 2018 - 2030 (USD Million)
  • Table 11 Pharmaceuticals Veterinary Orthopedic Medicine market by region, 2018 - 2030 (USD Million)
  • Table 12 Veterinary Orthopedic Medicine Canine market by region, 2018 - 2030 (USD Million)
  • Table 13 Veterinary Orthopedic Medicine Feline market by region, 2018 - 2030 (USD Million)
  • Table 14 Veterinary Orthopedic Medicine Equine market by region, 2018 - 2030 (USD Million)
  • Table 15 Veterinary Orthopedic Medicine Cattle market by region, 2018 - 2030 (USD Million)
  • Table 16 Veterinary Orthopedic Medicine Swine market by region, 2018 - 2030 (USD Million)
  • Table 17 Veterinary orthopedic medicine Osteoarthrtitis market, by use case, 2018 - 2030, (USD Million)
  • Table 18 Veterinary Orthopedic Medicine Degenerative Joint Diseases (DJD) market by region, 2018 - 2030 (USD Million)
  • Table 19 Veterinary orthopedic medicine Joint Inflammation/Pain market, by region 2018 - 2030, (USD Million)
  • Table 20 Veterinary Orthopedic Medicine Oral by region, 2018 - 2030 (USD Million)
  • Table 21 Veterinary Orthopedic Medicine Parenteral market by region, 2018 - 2030 (USD Million)
  • Table 22 Veterinary Orthopedic Topical market by region, 2018 - 2030 (USD Million)
  • Table 23 Veterinary Orthopedic Medicine Veterinary Hospitals market by region, 2018 - 2030 (USD Million)
  • Table 24 Veterinary Orthopedic Medicine Veterinary Clinics market by region, 2018 - 2030 (USD Million)
  • Table 25 North America Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 26 North America Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 27 North America Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 28 North America Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 North America Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 30 U.S. Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 31 U.S. Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 32 U.S. Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 33 U.S. Veterinary Orthopedic Medicine market By Route of Administration, 2018 -
  • Table 34 U.S. Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 35 Canada Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 36 Canada Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 37 Canada Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 38 Canada Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Canada Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 40 Mexico Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 41 Mexico Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 42 Mexico Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 43 Mexico Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Mexico Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 45 Europe Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 46 Europe Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 47 Europe Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 48 Europe Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Europe Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 50 Germany Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 51 Germany Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 52 Germany Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 53 Germany Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Germany Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 55 UK Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 56 UK Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 57 UK Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 58 UK Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 UK Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 65 China Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 66 China Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 China Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 70 Japan Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 72 Japan Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 73 Japan Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 75 India Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 76 India Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 77 India Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 78 India Veterinary Orthopedic Medicine market By Route of Aministration, 2018 - 2030 (USD Million)
  • Table 79 India Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Koreaa Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 81 South Korea Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 82 South Korea Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 83 South Korea Veterinary Orthopedic Medicine market By Route of Aministration, 2018 - 2030 (USD Million)
  • Table 84 South Korea Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 85 Brazil Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 86 Brazil Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 87 Brazil Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 88 Brazil Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 89 Brazil Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa Veterinary Orthopedic Medicine market By Product type, 2018 - 2030 (USD Million)
  • Table 91 Middle East & Africa Veterinary Orthopedic Medicine market By Animal type, 2018 - 2030 (USD Million)
  • Table 92 Middle East & Africa Veterinary Orthopedic Medicine market By Application, 2018 - 2030 (USD Million)
  • Table 93 Middle East & Africa Veterinary Orthopedic Medicine market By Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Middle East & Africa Veterinary Orthopedic Medicine market by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Veterinary Orthopedic Medicine Market Segmentation
  • Fig. 2 Disease Epidemiology
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Veterinary Orthopedic Medicine - Market Size and Growth Prospects (USD Million)
  • Fig. 12 Veterinary Orthopedic Medicine Market: Industry Value Chain Analysis
  • Fig. 13 Veterinary Orthopedic Medicine Market: Market Dynamics
  • Fig. 14 Veterinary Orthopedic Medicine Market: PORTER's Analysis
  • Fig. 15 Veterinary Orthopedic Medicine Market: PESTEL Analysis
  • Fig. 16 Veterinary Orthopedic Medicine Market Share By Product type, 2023 & 2030 (USD Million)
  • Fig. 17 Veterinary Orthopedic Medicine Market, By Product type: Market Share, 2023 & 2030
  • Fig. 18 Biologics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Viscosupplements Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Pharmaceuticals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Veterinary Orthopedic Medicine Market Share By Animal type, 2023 & 2030 (USD Million)
  • Fig. 22 Veterinary Orthopedic Medicine Market, By Animal type: Market Share, 2023 & 2030
  • Fig. 23 Canine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Feline Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Equine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Cattle Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Swine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 28 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Veterinary Orthopedic Medicine Market Share By Application, 2023 & 2030 (USD Million)
  • Fig. 30 Veterinary Orthopedic Medicine Market, By Application: Market Share, 2023 & 2030
  • Fig. 31 Osteoarthritis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 32 Dengenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 33 Joint Inflammaition/Pain Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Veterinary Orthopedic Medicine Market Share By Route of Administration, 2023 & 2030 (USD Million)
  • Fig. 37 Veterinary Orthopedic Medicine Market, By Route of Administration: Market Share, 2023 & 2030
  • Fig. 38 Oral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Parenteral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 Veterinary Orthopedic Medicine Market, by End-Use: Key Takeaways
  • Fig. 41 Veterinary Orthopedic Medicine Market, by End-Use: Market Share, 2023 & 2030
  • Fig. 42 Veterinary Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 43 Veterinary Clinics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 44 Other Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 45 Veterinary Orthopedic Medicine Market Revenue, by Region, 2023 & 2030, (USD Million)
  • Fig. 46 Regional Marketplace: Key Takeaways
  • Fig. 47 Regional Marketplace: Key Takeaways
  • Fig. 48 North America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Canada Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Europe Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UK Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 53 Germany Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 France Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Italy Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Spain Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific Veterinary Orthopedic Medicine Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 China Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 India Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Mexico Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 MEA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 KSA Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 UAE Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait Veterinary Orthopedic Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key Company Categorization
  • Fig. 77 Company Market Positioning
  • Fig. 78 Key Company Market Share Analysis, 2023
  • Fig. 79 Strategic Framework